Morphological and quantitative changes of the initial myocardial lymphatics in terminal heart failure

Lymphatic Research and Biology

Volumn 7, Issue 1, 2009, Pages 21-27

  Dashkevich, Alexey ^a   Bloch, Wilhelm ^b   Antonyan, Albert ^b   Fries, Jochen U W ^c   Geissler, Hans Joachim ^a,d  

^a UNIVERSITY OF FREIBURG   (Germany)

^b GERMAN SPORT UNIVERSITY COLOGNE   (Germany)

^c UNIVERSITY OF COLOGNE   (Germany)

^d TEXAS A AND M UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIAL CELL GROWTH FACTOR; LYVE 1; PARAFFIN; PROX 1; UNCLASSIFIED DRUG; VASCULOTROPIN RECEPTOR 3;

ADULT; ARTICLE; BLOOD VESSEL; CELL DENSITY; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; HEART FAILURE; HEART LEFT VENTRICLE; HEART MUSCLE; HEART MUSCLE BIOPSY; HEART TRANSPLANTATION; HUMAN; IMMUNOFLUORESCENCE TEST; IMMUNOHISTOCHEMISTRY; LYMPH VESSEL; LYMPHANGIOGENESIS; MALE; MORPHOLOGICAL TRAIT; ORGAN DONOR; PRIORITY JOURNAL; QUANTITATIVE TRAIT; RECIPIENT;

ADULT; AGED; BIOLOGICAL MARKERS; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; GRAFT REJECTION; HEART FAILURE; HEART TRANSPLANTATION; HOMEODOMAIN PROTEINS; HUMANS; IMMUNOENZYME TECHNIQUES; LYMPHATIC SYSTEM; MALE; MIDDLE AGED; MYOCARDIUM; TISSUE DONORS; TUMOR SUPPRESSOR PROTEINS; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-3; VESICULAR TRANSPORT PROTEINS;

EID: 62949243351     PISSN: 15396851     EISSN: None     Source Type: Journal    
DOI: 10.1089/lrb.2008.1010     Document Type: Article

References (31)

1. Bleumink GS, Knetsch AM, Sturkenboom MC, Straus SM, Hofman A, Deckers JW, Witteman JC, Stricker BH. Quantifying the heart failure epidemic: prevalence, incidence rate, lifetime risk and prognosis of heart failure The Rotterdam Study. Eur Heart J 2004;25:1614-1619.
2. Laine GA. Microvascular changes in the heart during chronic arterial hypertension. Circ Res 1988;62:953-960.
3. Leeds SE, Uhley HN, Teleszky LB. Direct cannulation and injection lymphangiography of the canine cardiac and pulmonary efferent mediastinal lymphatics in experimental congestive heart failure. Invest Radiol 1981;16:193-200.
4. Marchetti C, Poggi P, Calligaro A, Arbustini E. Lymphatic system in human dilated cardiomyopathy. J Submicrosc Cytol Pathol 1988:20:701-708.
5. Laine GA, Allen SJ. Left ventricular myocardial edema. Lymph flow, interstitial fibrosis, and cardiac function. Circ Res 1991;68:1713-1721.
6. Mehlhorn U, Geissler HJ, Laine GA, Allen SJ. Myocardial fluid balance. Eur J Cardiothorac Surg 2001;20:1220-1230.
7. Laine GA, Allen SJ, Katz J, Gabel JC, Drake RE. Outflow pressure reduces lymph flow rate from various tissues. Microvasc Res 1987;33:135-142.
8. Banerji S, Ni J, Wang SX, Clasper S, Su J, Tammi R, Jones M, Jackson DG. LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan. J Cell Biol 1999;144:789-801.
9. Kaipainen A, Korhonen J, Mustonen T, van Hinsbergh VW, Fang GH, Dumont D, Breitman M, Alitalo K. Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development. Proc Natl Acad Sci USA 1995;92:3566-3570.
10. Wigle JT, Harvey N, Detmar M, Lagutina I, Grosveld G, Gunn MD, Jackson DG, Oliver G. An essential role for Prox1 in the induction of the lymphatic endothelial cell phenotype. EMBO J 2002;21:1505-1513.
11. Shimizu K, Kubo H, Yamaguchi K, Kawashima K, Ueda Y, Matsuo K, Awane M, Shimahara Y, Takabayashi A, Yamaoka Y, Satoh S. Suppression of VEGFR-3 signaling inhibits lymph node metastasis in gastric cancer. Cancer Sci 2004;95:328-333.
12. Skobe M, Hawighorst T, Jackson DG, Prevo R, Janes L, Velasco P, Riccardi L, Alitalo K, Claffey K, Detmar M. Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis. Nat Med 2001;7:192-198.
13. Cursiefen C, Cao J, Chen L, Liu Y, Maruyama K, Jackson D, Kruse FE, Wiegand SJ, Dana MR, Streilein JW. Inhibition of hemangiogenesis and lymphangiogenesis after normal-risk corneal transplantation by neutralizing VEGF promotes graft survival. Invest Ophthalmol Vis Sci 2004;45:2666-2673.
14. Geissler HJ, Dashkevich A, Fischer UM, Fries JW, Kuhn-Regnier F, Addicks K, Mehlhorn U, Bloch W. First year changes of myocardial lymphatic endothelial markers in heart transplant recipients. Eur J Cardiothorac Surg 2006;29:767-771.
15. Geissler HJ, Bloch W, Forster S, Mehlhorn U, Krahwinkel A, Kroener A, Addicks K, deVivie ER. Morphology and density of initial lymphatics in human myocardium determined by immunohistochemistry. Thorac Cardiovasc Surg 2003;51: 244-248.
16. Kong X-Q, Wang L-X, Kong D-G. Cardiac lymphatic interruption is a major cause for allograft failure after cardiac transplantation. Lymphat Res Biol 2007; 5:45-48.
17. Noll S, Schaub-Kuhnen S. Praxis der Immunhistochemie. Vol. 4. 7 ed. Urban & Fischer Verlag, 2000.
18. Onizawa K, Schmelzeisen R, Berens von RD, Schelomenzew J. Microanatomy of primary lymphatics in oral mucosa: a scanning electron microscopic study. Br J Oral Maxillofac Surg 1997;35:177-179.
19. Sacchi G, Weber E, Agliano M, Cavina N, Comparini L. Lymphatic vessels of the human heart: precollectors and collecting vessels. A morpho-structural study. J Submicrosc Cytol Pathol 1999;31:515-525.
20. Granger HJ, Laine GA, Barnes GE, Lewis RE. Dynamics and control of transmicrovascular fluid exchange. In: Edema, Staub NC, Taylor AE, Eds, Raven Press, New York, 1984: 189-199.
21. Parker JC, Perry MA, Taylor AE. Permeability of the microvascular barrier. In: Edema, Staub NC, Taylor AE, Eds, Raven Press, New York, 1984:143-187.
22. Laine GA, Granger HJ. Microvascular, interstitial, and lymphatic interactions in the normal heart. Am J Physiol 1985; 249:H834-H842.
23. Starling EH. On the absorption of fluids from the connective tissue spaces. J Physiol Lond 1896;19:312-326.
24. Curry FE. Mechanics and thermodynamics of transcapillary exchange. In: Handbook of Physiology, Section 2: The Cardiovascular System, Renkin EM, Michel CC, Eds. The American Physiological Society, Washington, 1994:309-374.
25. Ishikawa Y, Akishima-Fukasawa Y, Ito K, Akasaka Y, Tanaka M, Shimokawa R, Kimura-Matsumoto M, Morita H, Sato S, Kamata I, Ishii T. Lymphangiogenesis in myocardial remodelling after infarction. Histopathology 2007;51:345-353.
26. Banai S, Jaklitsch MT, Shou M, Lazarous DF, Scheinowitz M, Biro S, Epstein SE, Unger EF. Angiogenic-induced enhancement of collateral blood flow to ischemic myocardium by vascular endothelial growth factor in dogs. Circulation 1994;89:2183-2189.
27. Kawai Y, Hosaka K, Kaidoh M, Minami T, Kodama T, Ohhashi T. Heterogeneity in immunohistochemical, genomic, and biological properties of human lymphatic endothelial cells between initial and collecting lymph vessels. Lymphat Res Biol 2008;6:15-27.
28. Minami E, Laflamme MA, Saffitz JE, Murry CE. Extracardiac progenitor cells repopulate most major cell types in the transplanted human heart. Circulation 2005;112:2951-2958.
29. Liersch R, Nay F, Lu L, Detmar M. Induction of lymphatic endothelial cell differentiation in embryoid bodies. Blood 2006;107:1214-1216.
30. Al-Rawi MA, Mansel RE, Jiang WG. Molecular and cellular mechanisms of lymphangiogenesis. Eur J Surg Oncol 2005;31:117-121.
31. Shimoda H, Takahashi Y, Kato S. Development of the lymphatic network in the muscle coat of the rat jejunum as revealed by enzyme-histochemistry. Arch Histol Cytol 2001;64:523-533.